H, S., Y, F., C, M., J, L., A, M., M, L., & JB, W. (2025). Ciprofloxacin Dosage Optimization in Cystic Fibrosis Through Therapeutic Drug Monitoring. Therapeutic drug monitoring, 47(2), 189. https://doi.org/10.1097/FTD.0000000000001267
Chicago Style (17th ed.) CitationH, Sayadi, Fromage Y, Monchaud C, Languepin J, Masson-Rouchaud A, Labriffe M, and Woillard JB. "Ciprofloxacin Dosage Optimization in Cystic Fibrosis Through Therapeutic Drug Monitoring." Therapeutic Drug Monitoring 47, no. 2 (2025): 189. https://doi.org/10.1097/FTD.0000000000001267.
MLA (9th ed.) CitationH, Sayadi, et al. "Ciprofloxacin Dosage Optimization in Cystic Fibrosis Through Therapeutic Drug Monitoring." Therapeutic Drug Monitoring, vol. 47, no. 2, 2025, p. 189, https://doi.org/10.1097/FTD.0000000000001267.